IPAD-DB ID | S01221 |
Name | Azure C |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 3 H 1 2 C l N 3 S |
Molecular Weight | 277.77 g/mol |
IUPAC Name | 7-methyliminophenothiazin-10-ium-3-amine;chloride |
InChI | InChI=1S/C13H11N3S.ClH/c1-15-9-3-5-11-13(7-9)17-12-6-8(14)2-4-10(12)16-11;/h2-7H, 14H2, 1H3;1H |
InChIKey | DDGMDTGNGDOUPX-UHFFFAOYSA-N |
Canonical SMILES | CN=C1C=CC2=[NH+]C3=C(C=C(C=C3)N)SC2=C1.[Cl-] |
PubChem CID | 135421845 |
DrugBank Accession Number | - |
CAS Registry Number | 531-57-7 |
Molecular Weight(Computed by SwissADME) | 277.77 |
Hac(Computed by SwissADME) | 18 |
Volume(Computed by ADMETlab 2.0) | 240.779 |
Density(Computed by ADMETlab 2.0) | 1.001 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.118 |
LogD(Computed by ADMETlab 2.0) | 2.08 |
logP(Computed by ADMETlab 2.0) | 2.803 |
TPSA(Computed by SwissADME) | 80.76 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.35 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |